MLL REARRANGEMENT
Clinical trials for MLL REARRANGEMENT explained in plain language.
Never miss a new study
Get alerted when new MLL REARRANGEMENT trials appear
Sign up with your email to follow new studies for MLL REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat leukemia: drug combo trial launches
Disease control Recruiting nowThis early-stage study tests a new drug called ziftomenib combined with standard treatments for people with a type of acute myeloid leukemia (AML) that has come back or not responded to therapy. The main goal is to check safety and find the best dose. About 171 adults with specif…
Matched conditions: MLL REARRANGEMENT
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated May 26, 2026 10:02 UTC
-
Stem cell test may forecast leukemia return
Knowledge-focused Recruiting nowThis study looks at whether measuring leukemia stem cells can help predict if acute myeloid leukemia (AML) with MLL rearrangement will come back. Researchers will test bone marrow samples from 210 patients aged 6-60 who are receiving chemotherapy or a stem cell transplant. The go…
Matched conditions: MLL REARRANGEMENT
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC